Results 161 to 170 of about 551,491 (329)
Screen chaotic motion by Shannon entropy in curved spacetimes
We find a novel characteristic for chaotic motion by introducing Shannon entropy for periodic orbits, quasiperiodic orbits, and chaotic orbits. We compare our approach with the previous methods including Poincaré section, Lyapunov exponent, fast Lyapunov
Wenfu Cao, Yang Huang, Hongsheng Zhang
doaj +1 more source
ON THE SIMILARITY OF CERTAIN ORBITS IN THE ZONE OF ASTEROIDS (SECOND PAPER) [PDF]
Daniel Kirkwood
openalex +1 more source
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
The Poynting-Robertson effect on meteor orbits
Stanley P. Wyatt, Fred L. Whipple
openalex +1 more source
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop+10 more
wiley +1 more source
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau+9 more
wiley +1 more source
On the Determination of the Orbital Elements of Eclipsing Variable Stars. I.
Henry Norris Russell
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source